Approaches to novel antidiabetic therapy.
D000818:Animals; D001120:Arginine / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D017481:Receptors, Somatostatin; D013004:Somatostatin / Q000031:analogs & derivatives / Q000494:pharmacology
D007004:Hypoglycemic Agents; D011956:Receptors, Cell Surface; D017481:Receptors, Somatostatin; D013004:Somatostatin; D005934:Glucagon; D001120:Arginine